| scholarly article | Q13442814 |
| P356 | DOI | 10.1053/JHEP.1997.V26.PM0009362359 |
| P698 | PubMed publication ID | 9362359 |
| P2093 | author name string | Kobayashi T | |
| Hasegawa K | |||
| Harihara Y | |||
| Kubota K | |||
| Makuuchi M | |||
| Takayama T | |||
| Miki K | |||
| Kusaka K | |||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | decision making | Q1331926 |
| P304 | page(s) | 1176-1181 | |
| P577 | publication date | 1997-11-01 | |
| P1433 | published in | Hepatology | Q15724398 |
| P1476 | title | Measurement of liver volume and hepatic functional reserve as a guide to decision-making in resectional surgery for hepatic tumors | |
| P478 | volume | 26 |
| Q98578054 | A Concise Review on Current Trends in Imaging and Surgical Management of Hepatocellular Carcinoma |
| Q39855009 | A Nomogram to Predict Hypertrophy of Liver Segments 2 and 3 After Right Portal Vein Embolization |
| Q36699413 | A multidisciplinary approach for the treatment of GIST liver metastasis |
| Q43263543 | A new approach to percutaneous transhepatic portal embolization using ethanolamine oleate iopamidol |
| Q34987961 | A novel application for the cavalieri principle: a stereological and methodological study |
| Q39377718 | A retrospective analysis of long term outcomes in patients undergoing hepatic resection for large (>5 cm) hepatocellular carcinoma |
| Q26749857 | A review of current status of living donor liver transplantation |
| Q33209415 | A two-stage hepatectomy procedure combined with portal vein embolization to achieve curative resection for initially unresectable multiple and bilobar colorectal liver metastases |
| Q37105542 | A worldwide survey of the current daily practice in liver surgery |
| Q42004327 | Accomplishments in 2007 in the management of hepatobiliary cancers. |
| Q33604595 | Assessment of future remnant liver function using hepatobiliary scintigraphy in patients undergoing major liver resection |
| Q97425681 | Associated liver partition and portal vein ligation for staged hepatectomy: a review |
| Q35534069 | Biliary drainage strategy of unresectable malignant hilar strictures by computed tomography volumetry |
| Q36897901 | CT/99mTc-GSA SPECT fusion images demonstrate functional differences between the liver lobes |
| Q40086224 | Chemotherapy and its effect on liver hypertrophy: implications for portal vein embolization and resection |
| Q40347363 | Chemotherapy does not impair hypertrophy of the left liver after right portal vein obstruction |
| Q38024277 | Chemotherapy-associated liver injury in patients with colorectal liver metastases: a systematic review and meta-analysis |
| Q53122958 | Clinical feasibility of inferior right hepatic vein-preserving trisegmentectomy 5, 7, and 8 (with video). |
| Q82621238 | Clinicopathologic characteristics of hepatocellular carcinoma with bile duct invasion |
| Q38240439 | Colorectal cancer with potentially resectable hepatic metastases: optimizing treatment |
| Q36213921 | Comparison of childhood hepatic malignancies in a hepatitis B hyper-endemic area |
| Q35006155 | Comparison of remnant to total functional liver volume ratio and remnant to standard liver volume ratio as a predictor of postoperative liver function after liver resection |
| Q40166023 | Comparison of two methods of future liver remnant volume measurement |
| Q37413297 | Complete hepatocellular carcinoma necrosis following sequential porto-arterial embolization. |
| Q38770147 | Complex Surgical Strategies to Improve Resectability in Borderline-Resectable Disease. |
| Q58604734 | Comprehensive Complication Index Validates Improved Outcomes Over Time Despite Increased Complexity in 3707 Consecutive Hepatectomies |
| Q36643483 | Comprehensive Predictors of Portal Pressure from Functional Liver Reserve in Patients Who Underwent Hepatectomy. |
| Q57160338 | Conversion therapy and suitable timing for subsequent salvage surgery for initially unresectable hepatocellular carcinoma: What is new? |
| Q47240122 | Correlation between preoperative serum concentration of type IV collagen 7s domain and hepatic failure following resection of hepatocellular carcinoma |
| Q38019845 | Current opinion on the role of resection and liver transplantation for hepatocellular cancer |
| Q36802509 | Current surgical treatment for bile duct cancer |
| Q64269104 | Current topics in liver surgery |
| Q92065917 | Dealing with an insufficient future liver remnant: Portal vein embolization and two-stage hepatectomy |
| Q92995300 | Decellularized liver scaffolds promote liver regeneration after partial hepatectomy |
| Q54293192 | Deficiency of the oxygen sensor PHD1 augments liver regeneration after partial hepatectomy. |
| Q38524318 | Defining Post Hepatectomy Liver Insufficiency: Where do We stand? |
| Q27014926 | Development of a research agenda for the management of metastatic colorectal cancer: proceedings from a multidisciplinary research consensus panel |
| Q26999043 | Diagnostic and therapeutic management of hepatocellular carcinoma |
| Q53584611 | Diagnostic value of measuring liver volume for detecting occult hepatic metastases from colorectal or gastric cancer. |
| Q36953803 | Does the placement of a cystic duct tube after a hepatic resection help reduce the incidence of post-operative bile leak? |
| Q36752396 | Effect of preoperative chemotherapy on postoperative liver regeneration following hepatic resection as estimated by liver volume |
| Q50240420 | Effects of oxaliplatin-based chemotherapy on liver function--an analysis of impact and functional recovery using the LiMAx test |
| Q53097302 | Estimate or calculate? How surgeons rate volumes and surfaces. |
| Q79895360 | Expression of transforming growth factor-alpha and -beta in hepatic lobes after hemihepatic portal vein embolization |
| Q78455960 | Extended hepatic resection for hepatocellular carcinoma in patients with cirrhosis: is it justified? |
| Q73630382 | Extension of the frontiers of surgical indications in the treatment of liver metastases from colorectal cancer: long-term results |
| Q41017630 | Factors associated with contralateral liver hypertrophy after unilateral radioembolization for hepatocellular carcinoma |
| Q91588992 | Fifty-year history of biliary surgery |
| Q43612866 | Formula for calculating standard liver volume in Indians. |
| Q40071003 | From diagnosis to treatment of hepatocellular carcinoma: An epidemic problem for both developed and developing world |
| Q83389029 | Fused 99m-Tc-GSA SPECT/CT imaging for the preoperative evaluation of postoperative liver function: can the liver uptake index predict postoperative hepatic functional reserve? |
| Q57494813 | Guidelines for Diagnosis and Treatment of Primary Liver Cancer in China (2017 Edition) |
| Q37478218 | Guidelines for the management of biliary tract and ampullary carcinomas: surgical treatment |
| Q81024857 | Hepatectomy as treatment of choice for hepatocellular carcinoma in elderly cirrhotic patients |
| Q74604755 | Hepatectomy for hepatocellular carcinoma: toward zero hospital deaths |
| Q86766488 | Hepatectomy for huge hepatocellular carcinoma: single institute's experience |
| Q93136834 | Hepatectomy: more complex operations and improved perioperative outcomes |
| Q34589820 | Hepatic clearance measured with (99m)Tc-GSA single-photon emission computed tomography to estimate liver fibrosis |
| Q43693563 | Hepatic resection combined with radiofrequency ablation for initially unresectable colorectal liver metastases after effective chemotherapy is a safe procedure with a low incidence of local recurrence |
| Q84958635 | Hepatocellular carcinoma--resection or transplant? |
| Q33881131 | Hepatocellular carcinoma: early-stage management challenges |
| Q36171275 | Hepatocellular carcinoma: natural history, current management, and emerging tools |
| Q84705137 | High risk of biliary fistula after isolated segment VIII liver resection |
| Q54234543 | Hong Kong Consensus Statements for the Management of Unresectable Hepatocellular Carcinoma. |
| Q43618666 | How can we safely climb the ALPPS? |
| Q41152785 | Hypertrophy of the Left Liver in Patients with Large Tumors in the Right Liver |
| Q38812498 | Identification of cofactors influencing hypertrophy of the future liver remnant after portal vein embolization-the effect of collaterals on embolized liver volume. |
| Q39056892 | Impact of future remnant liver volume on post-hepatectomy regeneration in non-cirrhotic livers |
| Q53487180 | Impact of preoperative planning using virtual segmental volumetry on liver resection for hepatocellular carcinoma. |
| Q37321973 | Impaired liver function attenuates liver regeneration and hypertrophy after portal vein embolization |
| Q36160776 | Improved liver function after portal vein embolization and an elective right hepatectomy |
| Q37430985 | Improved long-term survival after major resection for hepatocellular carcinoma: a multicenter analysis based on a new definition of major hepatectomy. |
| Q53430189 | Improved survival following right trisectionectomy with caudate lobectomy without operative mortality: surgical treatment for hilar cholangiocarcinoma. |
| Q35207762 | Improving Outcomes with Surgical Resection and Other Ablative Therapies in HCC. |
| Q55404575 | Indocyanine green identification for tumor infiltration or metastasis originating from hepatocellular carcinoma. |
| Q39341703 | Inferior right hepatic vein-preserving major right hepatectomy for hepatocellular carcinoma in patients with significant fibrosis or cirrhosis |
| Q37577610 | Is computed tomography volumetric assessment of the liver reliable in patients with cirrhosis? |
| Q36784864 | Kinetic growth rate after portal vein embolization predicts posthepatectomy outcomes: toward zero liver-related mortality in patients with colorectal liver metastases and small future liver remnant |
| Q48191639 | Left hepatectomy after right paramedian sectoriectomy. |
| Q50458059 | Liver failure after hepatocellular carcinoma surgery |
| Q37107288 | Liver failure following partial hepatectomy |
| Q33735333 | Liver regeneration after liver resection: clinical aspects and correlation with infective complications |
| Q36047321 | Liver volume in the cirrhotic patient: does size matter? |
| Q47756206 | Liver volume-based prediction model stratifies risks for hepatocellular carcinoma in chronic hepatitis B patients on surveillance |
| Q49596147 | Long-Term Outcomes of Ante-Situm Resection and Auto-Transplantation in Conventionally Unresectable Hepatocellular Carcinoma: A Single-Center Experience |
| Q47795094 | Long-term outcome of extended hemihepatectomy for hilar bile duct cancer with no mortality and high survival rate |
| Q26783874 | Management before hepatectomy for hepatocellular carcinoma with cirrhosis |
| Q52565360 | Measurement of Total Liver Volume Using the Energy Expenditure: A New Formula. |
| Q83340421 | Modified Japan Integrated Staging is currently the best available staging system for hepatocellular carcinoma patients who have undergone hepatectomy |
| Q83014897 | Modified liver-hanging maneuver designed to minimize blood loss during hepatic parenchymal transection in hemihepatectomy |
| Q34099099 | Multi-disciplinary treatment for cholangiocellular carcinoma |
| Q64943233 | Multidisciplinary management of recurrent and metastatic hepatocellular carcinoma after resection: an international expert consensus. |
| Q35703937 | NCCN clinical practice guidelines in oncology: hepatobiliary cancers |
| Q50014327 | Nicotinamide adenine dinucleotide biosynthesis promotes liver regeneration |
| Q38639481 | Nomogram for individualised prediction of liver failure risk after hepatectomy in patients with resectable hepatocellular carcinoma: the evidence from ultrasound data. |
| Q85614006 | One-stage hepatectomy following portal vein embolization for colorectal liver metastasis |
| Q90068282 | Optimizing hepatectomy for hepatocellular carcinoma in Asia-patient selection and special considerations |
| Q80213412 | Outcome of surgical treatment of hilar cholangiocarcinoma |
| Q91783635 | Outcomes of staged hepatectomies for liver malignancy |
| Q37623505 | Partial liver volume radioembolization induces hypertrophy in the spared hemiliver and no major signs of portal hypertension |
| Q46679542 | Percutaneous right portal vein embolization with polyvinyl alcohol particles in gastric cancer metastasis: report of a case |
| Q38030862 | Perihilar cholangiocarcinoma: a surgeon's viewpoint on current topics |
| Q83879857 | Portal hypertension: contraindication to liver surgery? |
| Q43703861 | Portal vein embolisation for extended hepatectomy: single-centre experience. |
| Q38199484 | Portal vein embolization and ligation for extended hepatectomy |
| Q37140671 | Portal vein embolization for hepatocellular carcinoma |
| Q38762480 | Portal vein embolization for induction of selective hepatic hypertrophy prior to major hepatectomy: rationale, techniques, outcomes and future directions |
| Q39315752 | Portal vein embolization improves rate of resection of extensive colorectal liver metastases without worsening survival. |
| Q38676385 | Portal vein embolization in extended liver resection |
| Q40613341 | Portal vein embolization vs. portal vein ligation for induction of hypertrophy of the future liver remnant |
| Q41695876 | Portal vein embolization with n-butyl-cyanoacrylate through an ipsilateral approach before major hepatectomy: single center analysis of 50 consecutive patients |
| Q34652519 | Portal vein embolization: rationale, technique, and current application |
| Q38238041 | Post hepatectomy liver failure: concept of management |
| Q35744955 | Post-Operative Complications in Living Liver Donors: A Single-Center Experience in China |
| Q90357661 | Precision surgery for primary liver cancer |
| Q47271469 | Predicting hepatic failure with a new diagnostic technique by preoperative liver scintigraphy and computed tomography: a pilot study in 123 patients undergoing liver resection |
| Q37278294 | Prediction of postoperative hepatic insufficiency by liver stiffness measurement (FibroScan((R))) before curative resection of hepatocellular carcinoma: a pilot study |
| Q80336394 | Predictive indices of morbidity and mortality after liver resection |
| Q50723691 | Predictors for early recurrence after hepatectomy for initially unresectable colorectal liver metastasis. |
| Q39533320 | Predictors of intraoperative blood loss in patients undergoing hepatectomy. |
| Q36065971 | Preoperative portal vein embolisation for primary and metastatic liver tumours: volume effects, efficacy, complications and short-term outcome. |
| Q26749318 | Preoperative portal vein embolization for hepatocellular carcinoma: Consensus and controversy |
| Q26774848 | Preoperative portal vein embolization in liver cancer: indications, techniques and outcomes |
| Q40021315 | Preoperative portal vein embolization using an amplatzer vascular plug |
| Q39210533 | Preoperative portal venous and hepatic arterial embolization of tumor |
| Q39987491 | Preoperative right portal vein embolisation: indications and results |
| Q37768893 | Pretreatment assessment of hepatocellular cancer: expert consensus conference |
| Q30432108 | Pretreatment assessment of hepatocellular carcinoma: expert consensus statement |
| Q35690751 | Protection of the liver during hepatic surgery |
| Q42927985 | Proteomic analysis of regenerating mouse liver following 50% partial hepatectomy |
| Q37687163 | Quality improvement for portal vein embolization |
| Q37214685 | Quantitative assessment of hepatic function and its relevance to the liver surgeon |
| Q37376714 | Radiation lobectomy: time-dependent analysis of future liver remnant volume in unresectable liver cancer as a bridge to resection. |
| Q88011611 | Radiofrequency ablation vs. hepatic resection for resectable colorectal liver metastases |
| Q28345635 | Reactivation of viral replication after liver resection in patients infected with hepatitis B virus |
| Q35761124 | Reductions in post-hepatectomy liver failure and related mortality after implementation of the LiMAx algorithm in preoperative work-up: a single-centre analysis of 1170 hepatectomies of one or more segments |
| Q80194082 | Relationship between CT volumetry and functional liver volume using technetium-99m galactosyl serum albumin scintigraphy in patients undergoing preoperative portal vein embolization before major hepatectomy: a preliminary study |
| Q34225028 | Remnant growth rate after portal vein embolization is a good early predictor of post-hepatectomy liver failure. |
| Q39383426 | Remnant liver volume-based predictors of postoperative liver dysfunction after hepatectomy: analysis of 625 consecutive patients from a single institution |
| Q64101443 | Resected Intrahepatic Cholangiocarcinoma with Anaphylactic Shock from a Preoperative Liver Function Test before Hepatectomy |
| Q63367376 | Right Portal Vein Ligation is as Efficient as Portal Vein Embolization to Induce Hypertrophy of the Left Liver Remnant |
| Q39754925 | Robotic radical resection for hilar cholangiocarcinoma: perioperative and long-term outcomes of an initial series |
| Q82664072 | Role of portal vein embolization in liver surgery: single centre experience in sixty-two patients |
| Q38366588 | Role of surgical resection for hepatocellular carcinoma based on Japanese clinical guidelines for hepatocellular carcinoma |
| Q90539595 | Safe Resection of Renal Cell Carcinoma with Liver Invasion Using Liver Hanging Technique Supported by Preoperative Portal Vein Embolization |
| Q39381768 | Safe and permissible limits of hepatectomy in obstructive jaundice patients |
| Q85302763 | Safe hepatectomy selection criteria for hepatocellular carcinoma patients: a validation of 336 consecutive hepatectomies. The BILCHE score |
| Q50769126 | Safety and effectiveness of left hepatic trisegmentectomy for hilar cholangiocarcinoma. |
| Q36473907 | Safety and efficacy of partial hepatectomy for huge (≥10 cm) hepatocellular carcinoma: a systematic review. |
| Q39331907 | Safety and efficacy of portal vein embolization before planned major or extended hepatectomy: an institutional experience of 358 patients |
| Q34606118 | Safety evaluation of donors for living-donor liver transplantation in Chinese mainland: a single-center report |
| Q42587878 | Selection criteria for liver resection in patients with hepatocellular carcinoma and chronic liver disease |
| Q30415026 | Selection for hepatic resection of colorectal liver metastases: expert consensus statement |
| Q37169718 | Selection of treatment modality for hepatocellular carcinoma according to the modified Japan Integrated Staging score |
| Q34563749 | Sequential transcatheter arterial chemoembolization and portal vein embolization for hepatocellular carcinoma: the university of Tokyo experience |
| Q73401920 | Simultaneous segmental obstruction of bile duct and portal vein markedly changes a population of biliary and hepatic cells in human liver |
| Q64242584 | Spleen stiffness and volume help to predict posthepatectomy liver failure in patients with hepatocellular carcinoma |
| Q40086263 | Standardized liver volumetry for portal vein embolization |
| Q36702931 | Stepwise approach to curative surgery using percutaneous transhepatic cholangiodrainage and portal vein embolization for severe bile duct injury during laparoscopic cholecystectomy: a case report. |
| Q40086254 | Strategies for resection using portal vein embolization: hepatocellular carcinoma and hilar cholangiocarcinoma. |
| Q26795530 | Strategies to increase the resectability of hepatocellular carcinoma |
| Q57157834 | Study protocol: HepaT1ca - an observational clinical cohort study to quantify liver health in surgical candidates for liver malignancies |
| Q38368535 | Summary of the 2010 AHPBA/SSO/SSAT Consensus Conference on HCC. |
| Q92184609 | Surgery for cholangiocarcinoma |
| Q87904066 | Surgical Strategy Based on Indocyanine Green Test for Chemotherapy-Associated Liver Injury and Long-Term Outcome in Colorectal Liver Metastases |
| Q54989355 | Surgical Treatment of Hepatocellular Carcinoma. |
| Q57116389 | Surgical management of hilar cholangiocarcinoma at Memorial Sloan Kettering Cancer Center |
| Q42429760 | Surgical options for initially unresectable colorectal liver metastases |
| Q27690723 | Surgical resection of high-risk hepatocellular carcinoma: patient selection, preoperative considerations, and operative technique |
| Q51843410 | Surgical strategies in patients with advanced hilar cholangiocarcinoma (Klatskin tumor). |
| Q34629377 | Surgical strategy for bile duct cancer: Advances and current limitations |
| Q35738752 | Surgical treatment of neuroendocrine liver metastases |
| Q81573118 | The "50-50 criteria" on postoperative day 5: an accurate predictor of liver failure and death after hepatectomy |
| Q39866131 | The Evaluation of Liver Function and Surgical Influence by ICGR15 after Chemotherapy for Colorectal Liver Metastases |
| Q36909317 | The Liver Segmental Volume Ratio for Noninvasive Detection of Cirrhosis: Comparison With Established Linear and Volumetric Measures |
| Q48191680 | The Pitfalls of Left Trisectionectomy or Central Bisectionectomy for Biliary Cancer: Anatomical Classification Based on the Ventral Branches of Segment VI Portal Vein Relative to the Right Hepatic Vein. |
| Q43121098 | The effects of bile duct obstruction on liver volume: an experimental study |
| Q35598081 | The value of residual liver volume as a predictor of hepatic dysfunction and infection after major liver resection |
| Q39060500 | The value of the combination of fibrosis index based on the four factors and future liver remnant volume ratios as a predictor on posthepatectomy outcomes |
| Q36663840 | Three-Dimensional Quantitative Evaluation of the Segmental Functional Reserve in the Cirrhotic Liver Using Multi-Modality Imaging |
| Q33558958 | Three-dimensional volumetry in 107 normal livers reveals clinically relevant inter-segment variation in size |
| Q39349638 | Transarterial Chemoembolization and Radioembolization across Barcelona Clinic Liver Cancer Stages |
| Q36327887 | Treatment for multiple bilobar liver metastases of colorectal cancer |
| Q38549768 | Treatment of Liver Cancer |
| Q40348784 | Two hundred forty consecutive portal vein embolizations before extended hepatectomy for biliary cancer: surgical outcome and long-term follow-up |
| Q37328011 | Two-dimensional assessment of submillimeter cancer-free margin area in colorectal liver metastases |
| Q42142649 | Ultrasound-guided liver resection: Early experience in a district general hospital |
| Q28080480 | Update in management of hepatocellular carcinoma in Eastern population |
| Q39868706 | Usefulness of measuring hepatic functional volume using technetium-99m galactosyl serum albumin scintigraphy in hilar bile duct carcinoma |
| Q37759928 | Uses and limitations of portal vein embolization for improving perioperative outcomes in hepatocellular carcinoma |
| Q37261385 | Volumetric and functional recovery of the remnant liver after major liver resection with prior portal vein embolization : recovery after PVE and liver resection |
| Q36268905 | Yttrium-90 Radioembolization of Hepatocellular Carcinoma-Performance, Technical Advances, and Future Concepts |
| Q53174366 | [Contralateral hepatic hypertrophy following unilateral yttrium-90 radioembolization : Implications for liver surgery]. |
| Q79268958 | [Living donor liver transplantation] |
| Q53625857 | [Mesohepatectomy-an alternative to extended hepatectomy in the treatment of central liver tumors]. |
| Q53641926 | [Right portal vein ligation prior to extended right hemihepatectomy for synchronous colorectal liver metastases]. |
Search more.